AASLD is proud to announce the 2027 leadership for the AASLD Governing Board and the AASLD Foundation Board of Trustees!   

These distinguished leaders bring expertise, strategic vision, and a deep dedication to advancing the field of hepatology. Their leadership will help guide AASLD and the AASLD Foundation as we continue to drive innovation, support groundbreaking research, and shape the future of liver disease care. Their terms begin January 1, 2027.

Incoming Councilor (2027-2032)  

Meena B. Bansal, MD, FAASLD 
Icahn School of Medicine at Mount Sinai 

After completing a Gastroenterology/Hepatology Fellowship at the University of Pennsylvania, Dr. Bansal joined the faculty at Mount Sinai in 2001. She maintained an NIH-funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV. Concurrently, Dr. Bansal held many leadership roles at Mount Sinai, including the inaugural Transplant Hepatology Fellowship Director, Director of Translational Research for the Liver Diseases Division, Medical Director of all Mount Sinai Hospital-Based Clinics, Chief Medical Officer of Mount Sinai Care, LLC, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President of Population Health for Quality and Efficiency. In these latter roles, she oversaw the generation of increased quality dollars in value-based contracts, created Mount Sinai’s first ambulatory pharmacy program, and addressed broad population health needs. Dr. Bansal has also served as the principal investigator for numerous clinical trials and clinical/translational investigator-initiated studies in MASH. She launched the Mount Sinai MASLD/MASH Center of Excellence in 2022 which has enrolled over 1,200 patients. Her service to AASLD has included Secretary (2019-2021) and Chair of key Committees/Task Forces including the Women’s Health Representative Group, Research Awards Committee, Cirrhosis Quality Collaborative Steering Committee, Patient Advisory Group, DDW Task Force, Steatotic Liver Disease Task Force, and the Liver Fibrosis and Cirrhosis SIG. In January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System. 

Incoming AASLD Foundation Chair-Elect (2027), AASLD Foundation Chair (2028-2030)  

Tamar H. Taddei, MD, FAASLD  
Yale University 

Tamar Taddei, MD, FAASLD, is Professor of Medicine and Vice Chief (Digestive Diseases) at Yale School of Medicine and Chief of Digestive Diseases at the VA Connecticut Health Care System. She serves the VA National GI and Hepatology Program as Chair of the HCC Subcommittee of the VA Hepatology Field Advisory Board. Her clinical interests focus on developing systems and programs to deliver outstanding multidisciplinary care to people with liver cancer. Her research focuses on studying outcomes in cirrhosis and liver cancer in Veterans and developing and conducting large-scale VA clinical trials. Passionate about mentoring and sponsoring the next generation, Dr. Taddei has been recognized for her dedication to the career advancement of trainees and junior faculty. Her prior service to AASLD includes serving as Treasurer, Chair of the Public Policy Committee, and member of the Nominating, Membership, and Education Committees.

Incoming AASLD Foundation Trustee (2027-2029) 

Paul Y. Kwo, MD, FAASLD  
Stanford University

Paul Y. Kwo, MD, FAASLD, is Professor of Medicine at Stanford University, where he serves as the Director of Hepatology and Vice Chair of Clinical Research in the Division of Gastroenterology/Hepatology. He maintains an active practice in transplant and general hepatology. His clinical and research interests include the evaluation and development of novel therapies for a variety of liver diseases, with a focus on viral hepatitis, metabolic disorders, and advanced liver disease. His prior service to AASLD has included membership on the Clinical Research Committee, Finance Committee, Nominating Committee, Foundation Development Committee, and Steering Committee for the Hepatitis C Special Interest Group. He is currently Chair of the Industry Advancement Committee. 

2027 Elections

The following AASLD members were approved by the Governing Board for the election slate for the Councilor-at-Large and Nominating Committee positions. These leadership roles will be voted on by the membership in September. Congratulations to all individuals selected for the slate.

2027 Councilor-at-Large
Sumeet Asrani, MD, MSc, Baylor, Scott & White Health
Naudia Jonassaint, MD, MHS, MBA, FAASLD, Emory University
Jorge Marrero, MD, MS, FAASLD, University of Pennsylvania

Nominating Committee Slate
David Assis, MD, Yale University
Vincent Chen, MD, MS, University of Michigan
Deepika Devuni, MBBS, University of Massachusetts – Amherst
Udeme Ekong, MD, MPH, FAASLD, Georgetown University Hospital
Jeffrey Kahn, MD, FAASLD, University of Southern California
Tatyana Kushner, MD, MSCE, Weill Cornell Medicine
Brian Lee, MD, MAS, University of Southern California
Ponni Perumalswami, MD, FAASLD, University of Michigan
Atoosa Rabiee, MD, Georgetown University Hospital
Neil Shah, MD, University of North Carolina at Chapel Hill